Fudan University
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1905-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.fudan.edu.cn
FUSCC Refractory TNBC Platform Study (FUTURE2.0)
Phase 2
Recruiting
- Conditions
- Triple-negative Breast Cancer
- First Posted Date
- 2023-03-01
- Last Posted Date
- 2023-11-14
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 120
- Registration Number
- NCT05749588
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, China
Monitoring Response to Neoadjuvant Chemotherapy in Breast Cancer Using Ultrafast DCE-MRI
Recruiting
- Conditions
- Breast Cancer
- First Posted Date
- 2023-02-27
- Last Posted Date
- 2023-02-27
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 80
- Registration Number
- NCT05744518
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
Short-course Radiotherapy Combined With Chemotherapy and Pd-1 Inhibitor for Locally Advanced Colon Cancer(TORCH-C)
Phase 2
Not yet recruiting
- Conditions
- Locally Advanced Colon Cancer
- Interventions
- First Posted Date
- 2023-02-17
- Last Posted Date
- 2023-02-17
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 120
- Registration Number
- NCT05732493
The Efficacy and Safety of Fluzoparib Plus Irinotecan as Second-line Treatment in Patients With Homologous Recombination Deficiency (HRD) Metastatic Colorectal Cancer.
Phase 2
Not yet recruiting
- Conditions
- Homologous Recombination Deficiency Alterations Metastatic Colorectal Cancer
- Interventions
- First Posted Date
- 2023-02-16
- Last Posted Date
- 2023-02-24
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 29
- Registration Number
- NCT05732129
- Locations
- 🇨🇳
Department of Colorectal Surgery Fudan University Shanghai Caner Center, Shanghai, Shanghai, China
Cohort of Twin Pregnancy and the Offspring
Recruiting
- Conditions
- Twin Pregnancy
- Interventions
- Other: All pregnant women with a twin pregnancy and the offspring
- First Posted Date
- 2023-02-14
- Last Posted Date
- 2025-03-14
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 1000
- Registration Number
- NCT05727085
- Locations
- 🇨🇳
Obstetrics and Gynecology Hospital of Fudan University, Shanghai, Shanghai, China
Maximal Cytoreductive Therapies on Post-treatment Metastases in Pts With mHSPC During Apalutamide Plus ADT Treatment
Phase 2
Not yet recruiting
- Conditions
- Castration-Sensitive Prostate CancerMetastatic Prostate Cancer
- Interventions
- Drug: androgen deprivation therapyProcedure: cytoreductive radical prostatectomy with/without pelvic lymph node dissectionRadiation: metastasis-directed therapy with radiation
- First Posted Date
- 2023-02-08
- Last Posted Date
- 2023-02-08
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 47
- Registration Number
- NCT05717582
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center Pudong Hospital, Shanghai, Shanghai, China
🇨🇳Fudan University Shanghai Cancer Center Xuhui Hospital, Shanghai, Shanghai, China
Segmentectomy for Ground Glass-dominant Invasive Lung Cancer (ECTOP-1012)
Phase 3
Recruiting
- Conditions
- Lung AdenocarcinomaSegmentectomy
- Interventions
- Procedure: Segmentectomy
- First Posted Date
- 2023-02-08
- Last Posted Date
- 2024-06-03
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 307
- Registration Number
- NCT05717803
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
Application of "Heidelberg Triangle" Dissection in Pancreatoduodenectomy and Distal Pancreatectomy
Recruiting
- Conditions
- Periampullary CarcinomaPancreatoduodenectomyPancreatic Cancer
- Interventions
- Procedure: TRIANGLE operation
- First Posted Date
- 2023-01-30
- Last Posted Date
- 2023-08-01
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 200
- Registration Number
- NCT05703581
- Locations
- 🇨🇳
Huadong Hospital affiliated to Fudan University, Shanghai, China
Dosimetric Limitation of Pelvic Bone and Peritoneal Space in Rectal Cancer Patients During Chemoradiotherapy
Not Applicable
Active, not recruiting
- Conditions
- Rectal Cancer
- Interventions
- Radiation: dosimetric limitation of pelvic bone and peritoneal space during radiotherapy
- First Posted Date
- 2023-01-18
- Last Posted Date
- 2023-01-18
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 200
- Registration Number
- NCT05688033
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
Oncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib as Second-line or Later Therapy in Patients With Advanced Hepatocellular Carcinoma
Phase 1
Recruiting
- Conditions
- Hepatocellular Carcinoma
- Interventions
- First Posted Date
- 2023-01-09
- Last Posted Date
- 2023-03-06
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 25
- Registration Number
- NCT05675462
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
© Copyright 2025. All Rights Reserved by MedPath